Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
13%
OVERLAP
BY WEIGHT
5
# OF OVERLAPPING
HOLDINGS
PSIL
32
HOLDINGS
42%
ALSO IN IBRN
IBRN
73
HOLDINGS
10%
ALSO IN PSIL
SECTOR DRIFT (PSIL minus IBRN)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PSIL |
Weight in IBRN |
Overlap | |
|---|---|---|---|---|
 |
NEUROCRINE BIOSCIENCES INC | 4.4% | 4.1% | 4.1% |
 |
ALKERMES PLC | 4.0% | 4.4% | 4.0% |
|
SUPERNUS PHARMACEUTICALS INC | 3.6% | 3.0% | 3.0% |
|
BRIGHT MINDS BIO | 5.1% | 0.9% | 0.9% |
|
RELMADA THERAPEUTICS INC | 9.3% | 0.5% | 0.5% |
PSIL Overweight Relative to IBRN
|
RELMADA THERAPEUTICS INC | 8.8% |
|
DEFINIUM THERAPEUTICS INC | 8.7% |
|
NEURONETICS, INC. | 5.7% |
|
ALTO NEUROSCIENCE INC | 4.7% |
|
BRIGHT MINDS BIO | 4.2% |
|
ABBVIE INC | 3.9% |
|
JOHNSON & JOHNSON | 3.7% |
 |
NUMINUS WELLNESS INC | 0.9% |
|
SUPERNUS PHARMACEUTICALS INC | 0.6% |
|
INDIA GLOBALIZATION CAPITAL, INC. | 0.5% |
PSIL Underweight Relative to IBRN
|
AXSOME THERAPEUTICS, INC. | -4.8% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -4.6% |
 |
ARGENX SE ADR | -3.9% |
|
BIOGEN IDEC INC | -3.7% |
|
PTC THERAPEUTICS INC | -3.6% |
|
SCHOLAR ROCK HOLDING CORP. | -3.6% |
|
CATALYST PHARMACEUTICAL PART | -3.6% |
|
ACADIA PHARMACEUTICALS INC | -3.6% |
|
DIANTHUS THERAPEUTICS INC | -3.3% |
|
DENALI THERAPEUTICS INC. | -2.9% |